Cointime

PhagePro

company

About

PhagePro is an early-stage biotechnology therapeutics company.

  • 1 - 10

Highlights

Total Funding Amount
$3M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$3M
Industries
Biotechnology
Number Of Employee
1 - 10
Operating Status
Active

PhagePro is an early-stage biotechnology therapeutics company that develops bacteriophage-based products to help the world's most vulnerable communities.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$3M
PhagePro has raised a total of $3M in funding over 2 rounds. Their latest funding was raised on Mar 11, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 11, 2021 Grant $3M 1 National Institutes of Health — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
PhagePro is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
Cointime
เนื้อหา
บริษัท